C. Brown

发表

Chimeric antigen receptor signaling: Functional consequences and design implications

Leo D. Wang, Christine E. Brown, L. Wang, 2020, Science Advances.

Selective IL13Rα2-Targeted Functionality of IL13-Ligand CARs is Enhanced by Inclusion of 4-1BB Co-Stimulation

Leo D. Wang, B. Badie, S. Forman, 2022, bioRxiv.

Spatiotemporal analysis of glioma heterogeneity reveals COL1A1 as an actionable target to disrupt tumor progression

Anna E Argento, Patrick J. Dunn, Sébastien Motsch, 2022, Nature Communications.

Antibody-based redirection of universal Fabrack-CAR T cells selectively kill antigen bearing tumor cells

Jonathan C. Hibbard, John C Williams, John C. Williams, 2022, Journal for ImmunoTherapy of Cancer.

Conversion of a tumor-binding peptide identified by phage display to a functional chimeric T cell antigen receptor

M. Jensen, C. Wright, J. Wagner, 2006, Cancer Gene Therapy.

Data driven model discovery and interpretation for CAR T-cell killing using sparse identification and latent variables

Ryan T. Woodall, R. Rockne, Heyrim Cho, 2023, bioRxiv.

Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy

Jonathan C. Hibbard, I. Moraga, K. C. Garcia, 2022, Proceedings of the National Academy of Sciences of the United States of America.

Chimeric Antigen Receptor (CAR) T Cell Therapy for Glioblastoma

B. Badie, C. Brown, Lisa Feldman, 2021, NeuroMolecular Medicine.

Chimeric antigen receptor signaling: Functional consequences and design implications.

L. Wang, S. E. Lindner, S. Johnson, 2020, Science advances.

Inclusion of 4-1BB Costimulation Enhances Selectivity and Functionality of IL13Rα2-Targeted Chimeric Antigen Receptor T Cells

Leo D. Wang, B. Badie, S. Forman, 2022, Cancer research communications.

Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL.

Christine E Brown, Wen-Chung Chang, S. Riddell, 2016, Blood.

T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia.

Xiuli Wang, Cedric E. Dos Santos, A. Mardiros, 2013, Blood.

The Cerebroventricular Environment Modifies CAR T Cells for Potent Activity against Both Central Nervous System and Systemic Lymphoma

Jinhui Wang, Xiwei Wu, Xiuli Wang, 2020, Cancer Immunology Research.

IFNg is Critical for CAR T Cell Mediated Myeloid Activation and Induction of Endogenous Immunity.

A. Ribas, Xiwei Wu, B. Badie, 2021, Cancer discovery.

PD-L1 positive astrocytes attenuate inflammatory functions of PD-1 positive microglia in models of autoimmune neuroinflammation

Patrick J. Dunn, Sébastien Motsch, Todd C. Hollon, 2022, Nature Communications.

A mathematical modeling approach to explore kinetics of Chimeric Antigen Receptor (CAR) T-cell Response in glioma: the CARRGO model

R. Rockne, Heyrim Cho, S. Branciamore, 2019 .

Donor-derived CD19-targeted chimeric antigen receptor T cells in adult transplant recipients with relapsed/refractory acute lymphoblastic leukemia

Xiuli Wang, I. Aldoss, S. Forman, 2023, Blood cancer journal.